Evidence map›Paper›PMID 36284572›Full record

ArticleThe Pan African medical journal2022

Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation: a case report.

Asmaa El Kebir, Evrard Niyonkuru, Mahmoud Alafifi, Nisrine Bennani Guebessi, Mehdi Karkouri, Rachid Aboutaieb

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Asmaa El KebirDepartment of Pathology, Ibn Rochd University Hospital Center, Casablanca, Morocco.
Evrard NiyonkuruDepartment of Pathology, Ibn Rochd University Hospital Center, Casablanca, Morocco.
Mahmoud AlafifiFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
Nisrine Bennani GuebessiDepartment of Pathology, Ibn Rochd University Hospital Center, Casablanca, Morocco.
Mehdi KarkouriDepartment of Pathology, Ibn Rochd University Hospital Center, Casablanca, Morocco.
Rachid AboutaiebFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
University of Hassan II Casablanca · MACentre Hospitalier Universitaire Ibn Rochd · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation is a very extremely rare tumor and only few cases have been reported in the literature. Here we report a case of a 37-year-old woman who presented with a pain and a palpable mass in the right flank. The abdominal computed tomography (CT) scan found a renal tumor and the patient underwent a right radical nephrectomy with adrenal gland resection. After the histological examination of the specimen completed by immunohistochemical and molecular study, a diagnosis of chromophobe renal cell carcinoma with liposarcomatous dedifferentiation was made. The patient received adjuvant chemotherapy. Afterwards, she developed bone metastasis and died 13 months after the surgery. Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation is a rare tumor associated with a poor prognosis and a metastatic potential.

Indexed as

Bone NeoplasmsCarcinoma, Renal CellKidney NeoplasmsAdultFemaleHumansNephrectomyTomography, X-Ray Computedcase reportChromophobe renal cell carcinomaKidney neoplasmliposarcomatous dedifferentiation

Identifiers

PMID36284572
PMCPMC9547027
OpenAlexW4307493697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.